Market Cap 601.91M
Revenue (ttm) 3.55M
Net Income (ttm) -187.35M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -5,277.47%
Debt to Equity Ratio 0.00
Volume 512,500
Avg Vol 1,042,006
Day's Range N/A - N/A
Shares Out 40.62M
Stochastic %K 92%
Beta 1.31
Analysts Strong Sell
Price Target $25.55

Latest News on KROS

Keros Reinforces Commitment to Maximizing Stockholder Value

May 8, 2025, 5:31 PM EDT - 4 weeks ago

Keros Reinforces Commitment to Maximizing Stockholder Value


Crude Oil Falls Over 4%; Keros Therapeutics Shares Jump

Apr 10, 2025, 12:12 PM EDT - 2 months ago

Crude Oil Falls Over 4%; Keros Therapeutics Shares Jump


Keros Therapeutics adopts 'poison pill' plan

Apr 10, 2025, 6:10 AM EDT - 2 months ago

Keros Therapeutics adopts 'poison pill' plan


Keros Therapeutics Announces Review of Strategic Alternatives

Apr 10, 2025, 6:00 AM EDT - 2 months ago

Keros Therapeutics Announces Review of Strategic Alternatives